- Home
- GERN vs AXL Comparison
GERN vs AXL Comparison
Compare GERN & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- AXL
- Stock Information
- Founded
- GERN 1990
- AXL 1994
- Country
- GERN United States
- AXL United States
- Employees
- GERN N/A
- AXL N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- AXL Auto Parts:O.E.M.
- Sector
- GERN Health Care
- AXL Consumer Discretionary
- Exchange
- GERN Nasdaq
- AXL Nasdaq
- Market Cap
- GERN 700.6M
- AXL 690.6M
- IPO Year
- GERN 1996
- AXL 1999
- Fundamental
- Price
- GERN $1.46
- AXL $5.83
- Analyst Decision
- GERN Buy
- AXL Hold
- Analyst Count
- GERN 8
- AXL 7
- Target Price
- GERN $3.71
- AXL $6.14
- AVG Volume (30 Days)
- GERN 12.0M
- AXL 3.9M
- Earning Date
- GERN 08-06-2025
- AXL 08-08-2025
- Dividend Yield
- GERN N/A
- AXL N/A
- EPS Growth
- GERN N/A
- AXL 3967.82
- EPS
- GERN N/A
- AXL 0.35
- Revenue
- GERN $164,447,000.00
- AXL $5,833,200,000.00
- Revenue This Year
- GERN $159.14
- AXL N/A
- Revenue Next Year
- GERN $52.76
- AXL N/A
- P/E Ratio
- GERN N/A
- AXL $16.81
- Revenue Growth
- GERN 11877.20
- AXL N/A
- 52 Week Low
- GERN $1.09
- AXL $3.00
- 52 Week High
- GERN $4.83
- AXL $7.03
- Technical
- Relative Strength Index (RSI)
- GERN 59.63
- AXL 70.74
- Support Level
- GERN $1.26
- AXL $5.40
- Resistance Level
- GERN $1.55
- AXL $5.87
- Average True Range (ATR)
- GERN 0.09
- AXL 0.27
- MACD
- GERN 0.02
- AXL 0.05
- Stochastic Oscillator
- GERN 75.00
- AXL 88.95
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About AXL American Axle & Manufacturing Holdings Inc.
American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.